VCU Massey Cancer Center researcher John Hackett, Ph.D., is at the forefront of integrating computer simulations with laboratory experiments to understand complex biological systems at the molecular level. His work has tremendous implications for the development of drugs to treat a range of diseases and is so significant that the National Institutes of Health has funded his team for more than a decade. Earlier this year, Hackett received a four-year, $1.5 million R01 grant from the National Institute of General Medical Sciences (NIGMS) to unlock the secrets of cytochromes P450 (CYPs).
At age 40, Kathy Funk received her first cancer diagnosis. After hearing the sobering news, she remembers vividly the advice a nurse gave her as she left her doctor’s office: Get over to VCU Massey Cancer Center. Kathy has rarely been so grateful for the advice that saved her life.
VCU Massey Cancer Center has merged two of its existing research programs into the newly established Cancer Biology (CB) program. The former Cancer Cell Signaling (CCS) and Cancer Molecular Genetics (CMG) research programs have been consolidated into one new program, which will be led by Massey researcher Azeddine Atfi, Ph.D.
Robert Winn, M.D., director of VCU Massey Cancer Center, has been working hard to broaden access to cancer care through a community-engaged cancer center approach. Joining VCU less than a year ago, Winn is committed to reducing cancer disparities and ultimately making a bigger impact on the community.
Thanks to philanthropic leadership, Massey Cancer Centers’ immunotherapy research program received a booster shot of more than $6.6 million to support the cancer center’s immuno-oncology efforts through research, clinical trials and the recruitment and retention of talented physician-scientists working to advance treatment options.